Search results

83 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Researchers find new approach to treat drug-resistant HER2-positive breast cancer
Using human cancer cell lines, UNC scientists identified various ways that HER2-positive breast cancer tumors resist therapy, and they discovered a potential combination therapy to overcome multiple mechanisms of resistance and kill cancer cells.
Located in News
UNC Lineberger-led study tests drug strategy for aggressive breast cancer in the brain
Results from a UNC Lineberger-led study were published Monday in the journal Molecular Cancer Therapeutics. The pre-clinical study was the first to investigate one particular drug strategy as a treatment for breast cancer after it's spread to the brain.
Located in News
Researchers explore roots of breast cancer disparities at symposium
A symposium co-sponsored by the UNC Lineberger Comprehensive Cancer Center brought leading breast cancer researchers together Friday to share findings about the genetic and environmental factors driving disparities in the disease’s incidence and mortality.
Located in News
Perou recognized as health care innovator, awarded Triangle Business Journal honor
Charles M. Perou, PhD, professor of genetics and pathology at the University of North Carolina School of Medicine and the basic science leader of the UNC Lineberger Comprehensive Cancer Center Breast Cancer Research Program, has been acknowledged as a health care innovator by the Triangle Business Journal. During an awards ceremony on Thursday, Perou was selected from a pool of candidates as the finalist in the 2015 TBJ Health Care Heroes – Innovator category.
Located in News
Melissa Troester, PhD – Team Science at its Best
UNC Lineberger member Melissa Troester, PhD, values a team approach in her work and her personal life. As co-leader of the cancer center’s Cancer Epidemiology Program, Troester’s work is an important part of UNC Lineberger’s interdisciplinary research on the causes of breast cancer and the translational research on strategies of prevention, treatment and cure.
Located in News
Breast cancer prevention drug benefit varies among at-risk women, study finds
After weighing the risk of serious side effects with the benefits of a breast cancer prevention drug, a study led by a University of North Carolina at Chapel Hill researcher found that the drug’s benefits outweighed risks for most, but not all women.
Located in News
Tumor microenvironment is a rough neighborhood for nanoparticle cancer drugs
Researchers look at area around tumors to help personalize treatment for triple-negative breast cancer
Located in News
UNC Lineberger members present at 2014 San Antonio Breast Cancer Symposium
UNC Lineberger members Lisa Carey, MD, Chuck Perou, PhD, Hyman Muss, MD, Carey Anders, MD, and Katherine Hoadley, PhD will present at leading breast cancer research symposium.
Located in News
Carey named newly elected member of ASCO Nominating Committee
Lisa Carey, MD, medical director of the UNC Breast Center, division chief of hematology and oncology at the UNC School of Medicine, and physician-in-chief of the N.C. Cancer Hospital, has been named to the American Society of Clinical Oncology (ASCO) Nominating Committee. An ASCO member since 1997, Carey will serve a three-year term on the committee.
Located in News
Nichols awarded $200,000 Avon grant to study pregnancy-associated breast cancer
The 12th annual Avon Walk for Breast Cancer season concluded with the Charlotte Walk on October 26, raising $1.4 million to accelerate breast cancer research and improve access to screening, diagnosis, treatment and education. Hazel Nichols, PhD, assistant professor epidemiology at UNC Gillings School of Global Public Health is leading one of five teams in the Carolinas awarded a grant of $200,000 to support a study that will analyze data from 18 ongoing studies on pregnancy-associated breast cancer.
Located in News